Wacker Chemie Ag · XETR:WCH

Wacker Chemie — Investor Day (September 2026)

53 slides from Wacker Chemie's investor day presentation, Sep 17, 2026

  1. Slide 1: Capital Markets Day 2026

    Capital Markets Day 2026 London, September 17, 2026 Dr. Christian Hartel, CEO Dr. Tobias Ohler, CFO

  2. Slide 2: Disclaimer

    Disclaimer The information contained in this presentation is for background purposes only and is subject to amendment, revision and updating. Certain statements and information contained in this presentation may relate to future expectations and other forward-looking statements that are based on man

  3. Slide 3: WACKER CMD 2026: REFOCUS to unlock full potential

    WACKER CMD 2026: REFOCUS to unlock full potential Capital Markets Day 2026, London, September 17, 2026 3

  4. Slide 4: Agenda for today

    WACKER CMD 2026 – REFOCUS to unlock full potential Agenda for today REFOCUS to unlock full potential Capital Markets Day 2026, London, September 17, 2026 4

  5. Slide 5: Agenda for today

    WACKER CMD 2026 – REFOCUS to unlock full potential Agenda for today REFOCUS to unlock full potential Capital Markets Day 2026, London, September 17, 2026 5

  6. Slide 6: WACKER has leading market positions in all segments

    WACKER has leading market positions in all segments # WACKER market position Silicones Polymers Biosolutions Polysilicon Innovative specialties and Leading VAE-based adhesive Cutting-edge technologies Ultra-pure polysilicon solutions for & coating solutions tailored to for Healthcare and for next-ge

  7. Slide 7: Serving diverse global markets through four segments

    Serving diverse global markets through four segments Sales by segment Regions End markets % Sales 2025: €5.5B Biosolutions Rest of World Others Polysilicon Americas Automotive & Mobility Energy & Transmission Healthcare & Wellbeing Polymers Asia Electronics & Semiconductor Chemicals & Industries Sil

  8. Slide 8: Pursuing selective growth across diverse markets

    Pursuing selective growth across diverse markets​ Well-diversified market exposure End markets with different growth profiles % Sales 2025, in €5.5B Electronics & Semiconductor GDP++ Others Healthcare & Wellbeing GDP++ Automotive & Mobility Energy & Transmission Automotive & Mobility GDP+ Healthcare

  9. Slide 9: WACKER has adapted its focus to succeed in different dynamics

    WACKER has adapted its focus to succeed in different dynamics​ 2006-2012 2013-2021 2022-2025 Global expansion & end Increase profitability Growth & global footprint WACKER focus market diversification & cash expansion • Demand outpaced capacity • Specialties development • Customer pull accelerated K

  10. Slide 10: WACKER actively addresses new market challenges

    WACKER actively addresses new market challenges​ Post-Covid tailwinds turned to headwinds And how WACKER acted Significant oversupply in several chemical industries Initiated portfolio and footprint shift Structurally high European cost base for selected markets Protected margins and Increased globa

  11. Slide 11: Actions taken deliver results

    Actions taken deliver results​ How WACKER acted What we already achieved Expanded sites & asset base in China and India to capture regional growth Initiated portfolio and Build-up of low capital downstream footprint, e.g. Karlovy Vary for specialty silicones footprint shift Market leadership in semi

  12. Slide 12: Prepared for more downstream growth

    Prepared for more downstream growth Silicones Business Units Actions taken Electronics & Automotive Strengthened leadership in silicones chemistry & engineering know-how to provide high-end, customized specialties and solutions for diverse markets Consumer & Healthcare Leveraged global competence &

  13. Slide 13: Positioned to translate assets & expertise into commercial success

    Positioned to translate assets & expertise into commercial success Silicones Silicone value chain Downstream Upstream Midstream Specialties Solutions Characteristics Feedstock for captive use, Platform material defining Differentiation via Partnership-driven solutions high competitive pressure downs

  14. Slide 14: Recent CapEx focused on Mid- & Downstream, close to customers

    Recent CapEx focused on Mid- & Downstream, close to customers Silicones Downstream (Hybrid polymers) Mid- and Downstream (Resins / Precursors) (Nünchritz - DE) (Burghausen - DE) Downstream (RTV / LSR) Downstream (TIM / e-Mobility) (Tsukuba - JP) (Plzeň & Karlsbad - CZ) Downstream (M&A: BioMed Sc.) D

  15. Slide 15: Differentiated market positioning & focused pricing protect margins

    Differentiated market positioning & focused pricing protect margins Polymers Business Units Actions taken Implemented focused pricing playbook to counter raw material volatility, Dispersible maintain reliable customer service and protect margins Polymer Powders Leveraged leading application expertis

  16. Slide 16: Established Biotech platform, focus now on commercial excellence

    Established Biotech platform, focus now on commercial excellence Biosolutions Business Units Actions taken Implemented commercial excellence leadership strategy to fill established BioPharma capacities & leverage cutting-edge technologies & CDMO platform Launched customer partnerships & new innovati

  17. Slide 17: Extended Semi market leadership to support future growth

    Extended Semi market leadership to support future growth Polysilicon Business Units Actions taken Leveraged benchmark ultra-pure polysilicon to extend market leadership (~50% market share) and strengthen relationships with all high-end wafer suppliers Semi- conductor Designed and implemented new, sm

  18. Slide 18: WACKER in talks regarding Section 232 & maintains two scenarios

    WACKER in talks regarding Section 232 & maintains two scenarios Polysilicon Scenarios Possible outcomes Stringent incentive / protection of US solar market leads to rebound in solar volumes Semi & Solar Leverage 3 sites for semi and solar with continued focus on cost & efficiency EBITDA benefits fro

  19. Slide 19: The next step in WACKER's evolution is REFOCUS

    The next step in WACKER’s evolution is REFOCUS​ REFOCUS 2006-2012 2013-2021 2022-2025 2026-2028 Global expansion Increase Growth & Profitability, ROCE WACKER focus & end market profitability & cash global footprint and selected growth diversification expansion in attractive markets Strong global Vol

  20. Slide 20: Agenda for today

    WACKER CMD 2026 – REFOCUS to unlock full potential Agenda for today REFOCUS to unlock full potential Capital Markets Day 2026, London, September 17, 2026 20

  21. Slide 21: WACKER defined strategic priorities for holistic REFOCUS

    WACKER defined strategic priorities for holistic REFOCUS ​ We unleash the potential of our Structure & Processes We elevate our Business Model & Value Proposition We excel with our People & Culture Capital Markets Day 2026, London, September 17, 2026 21

  22. Slide 22: We unleash the potential of our Structure & Processes

    ​We unleash the potential of our Structure & Processes​ We unleash the potential of our Structure & Processes Capital Markets Day 2026, London, September 17, 2026 22

  23. Slide 23: PACE cost and efficiency program progressing on track

    PACE cost and efficiency program progressing on track Structure & Processes Today Start Implementation implementation of all measures phase completed Q4 2025 Q1 2026 Q3 2026 Q4 2027 Q4 2028 PACE program Organizational Kick-off restructuring Capital Markets Day 2026, London, September 17, 2026 23

  24. Slide 24: PACE realizes savings via leaner structure and processes

    PACE realizes savings via leaner structure and processes Structure & Processes Saving categories Key levers to realize savings until 2028 Value-focused management of technical spending in production plants Non-personnel cost Optimize supply chains with structural savings in raw materials and supplie

  25. Slide 25: PACE delivers structural changes through reorganization

    PACE delivers structural changes through reorganization Structure & Processes Merging of operating units Reorganization of engineering processes # of operating units # of organizational units Silicones 26 13 Departments 7 4 Polymers 8 5 • Merge operations into larger functional units, with • Align e

  26. Slide 26: PACE to deliver >€300M in gross savings per year by 2028

    PACE to deliver >€300M in gross savings per year by 2028 Structure & Processes First achievements of PACE measures Structural impact # of jobs reduced in Germany since 2024 1,600 Lower structural break-even and higher resilience 800 Capacity to fund innovation, technology & attractive markets €M sav

  27. Slide 27: Advanced digital foundation enables AI scaling for greater impact

    Advanced digital foundation enables AI scaling for greater impact Structure & Processes Scaling up for greater impact o ERP AI and backbone integration o Scaling AI across the organization o Process-driven and AI-ready ecosystem by 2030 Solid foundation established o Single ERP in place (S/4HANA tra

  28. Slide 28: We elevate Business Model & Value Proposition

    We elevate Business Model & Value Proposition​ We elevate our Business Model & Value Proposition Capital Markets Day 2026, London, September 17, 2026 28

  29. Slide 29: Portfolio management with differentiated steering to REFOCUS

    Portfolio management with differentiated steering to REFOCUS​ Business Model & Value Proposition Where we are coming from What is changing now Broad-based growth pursued due to customer pull Selective growth & tailored mission for each unit Uniform strategic and financial steering Differentiated ste

  30. Slide 30: WACKER introduces portfolio roles to steer businesses

    ​WACKER introduces portfolio roles to steer businesses​ Business Model & Value Proposition Portfolio Accelerate growth Optimize return Maximize cash Turnaround role Invest & scale high-value Turn strong market Generate dependable Restore competitiveness Mission solutions in attractive, positions int

  31. Slide 31: Portfolio roles reflect underlying end market dynamics

    ​Portfolio roles reflect underlying end market dynamics​ Business Model & Value Proposition Portfolio role based on matrix positioning and execution tailored to market specifics Turnaround Accelerate Fast-growing markets with attractive opportunities; growth focus on capturing structural growth Mark

  32. Slide 32: Differentiated steering directs innovation to Accelerate Growth

    ​Differentiated steering directs innovation to “Accelerate Growth” Business Model & Value Proposition Fast-growing end markets Recent launches E-Mobility & autonomous 12-14% Battery safety Sensor protection movement High performance Thermal management for Optical encapsulants 8-10% electronics semic

  33. Slide 33: Focused to strengthen strong performance in Optimize Return

    ​Focused to strengthen strong performance in “Optimize Return”​ Business Model & Value Proposition Attractive potential & market Actions taken Ultra-high-pure Expanded leadership position with new etching line, actions now focused semi polysilicon on automation, smart reactor technology and yield im

  34. Slide 34: Segment strategies reflect individual portfolio roles

    ​Segment strategies reflect individual portfolio roles Business Model & Value Proposition Silicones Polymers Biosolutions Polysilicon 17 portfolio units 3 portfolio units 3 portfolio units 2 portfolio units Drive asset-light Secure market and technology Build technology-led growth Extend #1 leadersh

  35. Slide 35: We excel with our People & Culture

    We excel with our People & Culture We excel with our People & Culture Capital Markets Day 2026, London, September 17, 2026 35

  36. Slide 36: Differentiated team capabilities to succeed in each portfolio role

    Differentiated team capabilities to succeed in each portfolio role People & Culture Accelerate • Proactive new-business hunting and disciplined execution of growth strategies growth • Customer-centric value creation through solution selling and faster commercialization Optimize • Strong financial ac

  37. Slide 37: WACKER launched program to build long-term winning teams

    WACKER launched program to build long-term winning teams People & Culture Grow together: Performance- and career management ONE WACKER Team Successful collaboration of Leading@WACKER diverse teams Upskilling program for leadership team Artificial Intelligence and GenAI Systematic training and applic

  38. Slide 38: Summary: REFOCUS to unlock full potential

    Summary: REFOCUS to unlock full potential​ Holistic program with defined strategic priorities for Structure, Business Model & People PACE cost program on track to deliver >€300M in gross savings per year Portfolio management & differentiated steering to be more selective in where we pursue growth Di

  39. Slide 39: Agenda for today

    WACKER CMD 2026 – REFOCUS to unlock full potential Agenda for today REFOCUS to unlock full potential Capital Markets Day 2026, London, September 17, 2026 39

  40. Slide 40: Solid chemicals – market headwinds held back performance

    Solid chemicals – market headwinds held back performance EBITDA development 2020-26 2.5 Financial resilience 2.0 Chemicals specialties growth with Market tailwinds expansion of global presence, close to turned to headwinds customers 1.5 in 2023 Semi polysilicon success & resilience 1.0 masked by sol

  41. Slide 41: Maintained solid financials & improved resilience

    Maintained solid financials & improved resilience ​ Strong liquidity Low net debt Reduced pension deficit High equity ratio 0.1x <1.0x 24% 48% 2.0 2.0 5 5 4 4 1.5 1.5 3 3 1.0 1.0 2 2 0.5 0.5 1 1 €B €B €B €B 2020 H1 2026 2020 2026e 2020 H1 2026 2020 H1 2026 Cash and cash equivalents Net debt Pension

  42. Slide 42: Pull levers to drive EBITDA margin to 15% ± 2pp

    Going forward: ​ Pull levers to drive EBITDA margin to 15% ± 2pp Historical EBITDA margin & ambition Growth 20% 15% • Proactive business hunting, drive selective ± 2pp specialties growth • Leverage assets & expertise into commercial success 15% Cost 10% • Deliver PACE >€300M gross cost savings per y

  43. Slide 43: Maintain CapEx < depreciation & leverage recent investments

    Going forward:​ Maintain CapEx < depreciation & leverage recent investments Development of CapEx and D&A​ in €M 710 666 547 466 344 300-400 269 D&A 224 Growth MoB & Efficiency 2020 2021 2022 2023 2024 2025 Ambition CapEx > depreciation to support growth according to more REFOCUS: CapEx < depreciatio

  44. Slide 44: Raise EBITDA & lower invest to drive ROCE sustainably >10%

    Going forward:​ Raise EBITDA & lower invest to drive ROCE sustainably >10% Historical ROCE and ambition ROCE Raise EBITDA 15% >10% • Drive selective growth, resilience • Cut costs 10% CapEx discipline • Leverage asset base • CapEx < depreciation 5% Optimize working capital 0% • Strict management 201

  45. Slide 45: Clear capital allocation priorities for selective growth & dividends

    Going forward: ​ Clear capital allocation priorities for selective growth & dividends Use of cash Cash flow invested in selective growth and maintain Selective growth & MoB competitive asset base Dividend policy unchanged: Distribute ~50% of net Dividends income Maintain solid financials: leverage ~

  46. Slide 46: Realize growth opportunities on pathway to Net Zero by 2045

    Going forward:​ Realize growth opportunities on pathway to Net Zero by 2045 Increased GHG from growth is offset… … by three priority initiatives Absolute GHG emissions (m t CO2e), Interim 2030 target -50% -50% Green Silicon Renewable electricity & Biocarbon 2025 (-43%)​​ Process Transformation Energ

  47. Slide 47: WACKER REFOCUS drives new financial ambitions

    WACKER REFOCUS drives new financial ambitions​ REFOCUS 2026-2028 Selective growth in attractive markets Profitability ROCE Capital Markets Day 2026, London, September 17, 2026 47

  48. Slide 48: Road to value creation – WACKER structural financial ambitions

    Road to value creation – WACKER structural financial ambitions​ GDP+ 15% ± 2pp >10% Focus on mix improvement & Structural EBITDA ROCE Accelerate Growth businesses margin band > cost of capital Capital Markets Day 2026, London, September 17, 2026 48

  49. Slide 49: Q3 2026 Trading Update

    Q3 2026 Trading Update Q3/26 supported by PACE and special income, group EBITDA expected at a same level as Q2/26 Chemicals EBITDA stable to slightly better than Q2/26 Chemicals Volatile raw materials, continued short-term order patterns Biosolutions EBITDA similar q/q, focus on filling capacities E

  50. Slide 50: We have a clear plan for REFOCUS

    We have a clear plan for REFOCUS​ Introduced portfolio roles to exploit full value reflecting individual fundamentals and dynamics Established a structure to guide resource allocation and steer each business Tailored innovation pipeline to enable strategic growth areas, e.g., in Electronics Achieve

  51. Slide 51: REFOCUS as solid foundation to lift growth and earnings

    REFOCUS as solid foundation to lift growth and earnings 2026 2028 Business Model REFOCUS & Value Proposition Selective growth Structure in attractive markets & Processes Profitability People & Culture ROCE Capital Markets Day 2026, London, September 17, 2026 51

  52. Slide 52: Q&A

    Q&A

  53. Slide 53: WACKER – Issuer, Contact and Additional Information

    WACKER – Issuer, Contact and Additional Investor relations contacts Financial Calendar Joerg Hoffmann, CFA Oct. 29, 2026 Q3 2026 Results Tel. +49 89 6279 1633 | joerg.hoffmann@wacker.com Scott McCollister Tel. +49 89 6279 1560 | scott.mccollister@wacker.com WACKER Chemie AG Publications Gisela-Stein

WACKER Chemie — Investor Day (September 2026) on 6ix